{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:26:03Z","timestamp":1791991563437,"version":"4.4.0"},"reference-count":220,"publisher":"Elsevier BV","issue":"10302","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K24-DK091419"],"award-info":[{"award-number":["K24-DK091419"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/s0140-6736(21)00519-5","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T19:09:34Z","timestamp":1624561774000},"page":"786-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1435,"title":["Chronic kidney disease"],"prefix":"10.1016","volume":"398","author":[{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazeen H","family":"Jafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon L","family":"Neuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(21)00519-5_bib1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib4","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: core curriculum 2019","volume":"74","author":"Ku","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/oemed-2018-105427","article-title":"Let's take the heat out of the CKDu debate: more evidence is needed","volume":"76","author":"Pearce","year":"2019","journal-title":"Occup Environ Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-002063","article-title":"The global and national burden of chronic kidney disease attributable to ambient fine particulate matter air pollution: a modelling study","volume":"5","author":"Bowe","year":"2020","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S0140-6736(21)00519-5_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","article-title":"The global burden of chronic kidney disease","volume":"395","author":"Cockwell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1681\/ASN.2012070675","article-title":"Association between younger age when first overweight and increased risk for CKD","volume":"24","author":"Silverwood","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MNH.0000000000000670","article-title":"Novel conservative management of chronic kidney disease via dialysis-free interventions","volume":"30","author":"Zarantonello","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/S0140-6736(21)00519-5_bib11","first-page":"S178","article-title":"Statistical selection of nutritional parameters in hemodialyzed patients","volume":"22","author":"Cano","year":"1987","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/S0140-6736(21)00519-5_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/sdi.12472","article-title":"Quality of life of patients with advanced chronic kidney disease receiving conservative care without dialysis","volume":"29","author":"Song","year":"2016","journal-title":"Semin Dial"},{"key":"10.1016\/S0140-6736(21)00519-5_bib13","article-title":"Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey","volume":"367","author":"Bello","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(21)00519-5_bib14","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2017121273","article-title":"Dialysis versus medical management at different ages and levels of kidney function in veterans with advanced CKD","volume":"29","author":"Kurella Tamura","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 2","key":"10.1016\/S0140-6736(21)00519-5_bib15","doi-asserted-by":"crossref","first-page":"ii91","DOI":"10.1093\/ndt\/gfw357","article-title":"Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease","volume":"32","author":"Kalantar-Zadeh","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/jpm.2011.0207","article-title":"Conservative management of end-stage renal disease without dialysis: a systematic review","volume":"15","author":"O'Connor","year":"2012","journal-title":"J Palliat Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJMp2001794","article-title":"Ensuring choice for people with kidney failure\u2014dialysis, supportive care, and hope","volume":"383","author":"Kalantar-Zadeh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MNH.0000000000000573","article-title":"Conservative vs preservative management of chronic kidney disease: similarities and distinctions","volume":"29","author":"Rhee","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/S0140-6736(21)00519-5_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.kint.2020.11.004","article-title":"Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere","volume":"99","author":"Kalantar-Zadeh","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib20","first-page":"181","article-title":"Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study","volume":"6","author":"Teehan","year":"1990","journal-title":"Adv Perit Dial"},{"key":"10.1016\/S0140-6736(21)00519-5_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2215\/CJN.03330414","article-title":"CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life","volume":"10","author":"Brown","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib22","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2215\/CJN.00510109","article-title":"Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?","volume":"4","author":"Carson","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/ndt\/gfq630","article-title":"Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy","volume":"26","author":"Chandna","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib24","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.2215\/CJN.01130112","article-title":"Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis","volume":"7","author":"Da Silva-Gane","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib25","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2012.6455","article-title":"Rates of treated and untreated kidney failure in older vs younger adults","volume":"307","author":"Hemmelgarn","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(21)00519-5_bib26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.ASN.0000054493.04151.80","article-title":"Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes","volume":"14","author":"Joly","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117718538","article-title":"A description of advanced chronic kidney disease patients in a major urban center receiving conservative care","volume":"4","author":"Kamar","year":"2017","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib28","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/ndt\/gfm153","article-title":"Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5","volume":"22","author":"Murtagh","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181345","article-title":"Survival analysis of conservative vs dialysis treatment of elderly patients with CKD stage 5","volume":"12","author":"Reindl-Schwaighofer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S0140-6736(21)00519-5_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000347220","article-title":"Trajectory of quality of life for poor prognosis stage 5D chronic kidney disease with and without dialysis","volume":"37","author":"Seow","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/gerona\/glt098","article-title":"Outcomes in older adults with stage 5 chronic kidney disease: comparison of peritoneal dialysis and conservative management","volume":"69","author":"Shum","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S0140-6736(21)00519-5_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nefro.2015.05.005","article-title":"Choosing conservative therapy in chronic kidney disease","volume":"35","author":"Teruel","year":"2015","journal-title":"Nefrologia"},{"key":"10.1016\/S0140-6736(21)00519-5_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2215\/CJN.07510715","article-title":"Comparative survival among older adults with advanced kidney disease managed conservatively versus with dialysis","volume":"11","author":"Verberne","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.kint.2019.12.002","article-title":"Kidney health for everyone everywhere-from prevention to detection and equitable access to care","volume":"97","author":"Li","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.EDE.0000071413.55296.c4","article-title":"Lifestyle factors, obesity and the risk of chronic kidney disease","volume":"14","author":"Stengel","year":"2003","journal-title":"Epidemiology"},{"key":"10.1016\/S0140-6736(21)00519-5_bib36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/j.ajkd.2013.12.012","article-title":"Cost-effectiveness of primary screening for CKD: a systematic review","volume":"63","author":"Komenda","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib38","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib39","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib41","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib43","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/S0140-6736(21)00519-5_bib44","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(21)00519-5_bib45","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.mayocp.2018.04.017","article-title":"Development and validation of prediction scores for early mortality at transition to dialysis","volume":"93","author":"Obi","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S0140-6736(21)00519-5_bib46","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1681\/ASN.2015101142","article-title":"Residual kidney function decline and mortality in incident hemodialysis patients","volume":"27","author":"Obi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117698669","article-title":"Obesity and kidney disease: hidden consequences of the epidemic","volume":"4","author":"Kovesdy","year":"2017","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib48","article-title":"Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium","volume":"364","author":"Chang","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(21)00519-5_bib49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173515","article-title":"Body-mass index and risk of advanced chronic kidney disease: prospective analyses from a primary care cohort of 1\u00b74 million adults in England","volume":"12","author":"Herrington","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S0140-6736(21)00519-5_bib51","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2213-8587(14)70156-1","article-title":"Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/nu12071931","article-title":"Plant-dominant low-protein diet for conservative management of chronic kidney disease","volume":"12","author":"Kalantar-Zadeh","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/S0140-6736(21)00519-5_bib53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.ajkd.2020.10.003","article-title":"Plant-based diets for kidney disease: a guide for clinicians","volume":"77","author":"Joshi","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib54","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.118.038341","article-title":"Lorcaserin and renal outcomes in obese and overweight patients in the CAMELLIA-TIMI 61 trial","volume":"139","author":"Scirica","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(21)00519-5_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ekir.2017.01.010","article-title":"Bariatric surgery and kidney-related outcomes","volume":"2","author":"Chang","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/S0140-6736(21)00519-5_bib56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.kint.2016.02.039","article-title":"Bariatric surgery is associated with improvement in kidney outcomes","volume":"90","author":"Chang","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0420","article-title":"Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial","volume":"155","author":"Cohen","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/S0140-6736(21)00519-5_bib58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pcad.2018.07.001","article-title":"Obesity paradox in advanced kidney disease: from bedside to the bench","volume":"61","author":"Naderi","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ekir.2017.01.009","article-title":"The obesity paradox in kidney disease: how to reconcile it with obesity management","volume":"2","author":"Kalantar-Zadeh","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/S0140-6736(21)00519-5_bib60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MNH.0000000000000212","article-title":"The dual roles of obesity in chronic kidney disease: a review of the current literature","volume":"25","author":"Rhee","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/S0140-6736(21)00519-5_bib61","doi-asserted-by":"crossref","first-page":"F263","DOI":"10.1152\/ajprenal.00171.2010","article-title":"Proinflammatory gene expression and renal lipogenesis are modulated by dietary protein content in obese Zucker fa\/fa rats","volume":"300","author":"Tovar-Palacio","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib62","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMra1700312","article-title":"Nutritional management of chronic kidney disease","volume":"377","author":"Kalantar-Zadeh","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib63","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.ajkd.2018.06.016","article-title":"The role for protein restriction in addition to renin-angiotensin-aldosterone system inhibitors in the management of CKD","volume":"73","author":"Koppe","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib64","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1681\/ASN.V10112426","article-title":"Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group","volume":"10","author":"Levey","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib65","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcsm.12264","article-title":"Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials","volume":"9","author":"Rhee","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/S0140-6736(21)00519-5_bib67","article-title":"Low protein diets for chronic kidney disease in non diabetic adults","volume":"3","author":"Fouque","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(21)00519-5_bib68","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1053\/ajkd.1998.v31.pm9631839","article-title":"A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function","volume":"31","author":"Kasiske","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.jrn.2019.07.005","article-title":"The effects of restricted protein diet supplemented with ketoanalogue on renal function, blood pressure, nutritional status, and chronic kidney disease-mineral and bone disorder in chronic kidney disease patients: a systematic review and meta-analysis","volume":"30","author":"Chewcharat","year":"2020","journal-title":"J Ren Nutr"},{"key":"10.1016\/S0140-6736(21)00519-5_bib70","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3945\/ajcn.112.036418","article-title":"Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy","volume":"97","author":"Kovesdy","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S0140-6736(21)00519-5_bib71","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/ki.2012.420","article-title":"The mean dietary protein intake at different stages of chronic kidney disease is higher than current guidelines","volume":"83","author":"Moore","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/j.jrn.2019.01.008","article-title":"Does kidney longevity mean healthy vegan food and less meat or is any low-protein diet good enough?","volume":"29","author":"Kalantar-Zadeh","year":"2019","journal-title":"J Ren Nutr"},{"key":"10.1016\/S0140-6736(21)00519-5_bib73","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2215\/CJN.12391018","article-title":"Plant-based diets and incident CKD and kidney function","volume":"14","author":"Kim","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib74","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1681\/ASN.2020010028","article-title":"The effects of high-protein diets on kidney health and longevity","volume":"31","author":"Ko","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.jrn.2018.06.006","article-title":"Adequacy of plant-based proteins in chronic kidney disease","volume":"29","author":"Joshi","year":"2019","journal-title":"J Ren Nutr"},{"key":"10.1016\/S0140-6736(21)00519-5_bib76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41581-020-00345-8","article-title":"Food as medicine: targeting the uraemic phenotype in chronic kidney disease","volume":"17","author":"Mafra","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib77","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ki.2015.255","article-title":"Probiotics and chronic kidney disease","volume":"88","author":"Koppe","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/j.jrn.2013.08.004","article-title":"Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases","volume":"23","author":"Chauveau","year":"2013","journal-title":"J Ren Nutr"},{"key":"10.1016\/S0140-6736(21)00519-5_bib79","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/CS20171107","article-title":"Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins","volume":"132","author":"Lau","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S0140-6736(21)00519-5_bib80","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.2012050503","article-title":"p-Cresyl sulfate promotes insulin resistance associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib82","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ndt\/gfr453","article-title":"Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients\u2014a prospective cohort study","volume":"27","author":"Wu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-020-0297-2","article-title":"Plant-based diets to manage the risks and complications of chronic kidney disease","volume":"16","author":"Carrero","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib84","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","article-title":"Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease","volume":"85","author":"Hung","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.ajkd.2013.06.011","article-title":"Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study","volume":"63","author":"Tsai","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib86","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001480","article-title":"Association of fluid retention with anemia and clinical outcomes among patients with chronic kidney disease","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S0140-6736(21)00519-5_bib87","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/hr.2010.47","article-title":"Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events","volume":"33","author":"Kimura","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/S0140-6736(21)00519-5_bib88","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1681\/ASN.2019090905","article-title":"A randomized trial of distal diuretics versus dietary sodium restriction for hypertension in chronic kidney disease","volume":"31","author":"Bov\u00e9e","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib89","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1159\/000508700","article-title":"Design and baseline characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) trial","volume":"51","author":"Agarwal","year":"2020","journal-title":"Am J Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib90","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","article-title":"Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis","volume":"39","author":"Kovesdy","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(21)00519-5_bib91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2215\/CJN.08960718","article-title":"Plant-based diets in CKD","volume":"14","author":"Clegg","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib92","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/164_2017_25","article-title":"Role of hyperkalemia in heart failure and the therapeutic use of potassium binders","volume":"243","author":"Sarwar","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib93","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.kint.2017.08.038","article-title":"Revisiting RAAS blockade in CKD with newer potassium-binding drugs","volume":"93","author":"Georgianos","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib94","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.ajkd.2005.03.003","article-title":"Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment","volume":"45","author":"Kraut","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib95","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","article-title":"Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis","volume":"14","author":"Navaneethan","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib96","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(18)32562-5","article-title":"Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial","volume":"393","author":"Wesson","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib97","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib98","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib99","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib100","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib101","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib102","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib103","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2007.10.040","article-title":"Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review","volume":"51","author":"Bomback","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib104","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib106","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib107","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/joim.12701","article-title":"Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial","volume":"283","author":"Obi","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib108","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jacc.2014.04.065","article-title":"Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population","volume":"64","author":"Sim","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib109","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/jamainternmed.2014.3279","article-title":"Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease","volume":"174","author":"Kovesdy","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2018.07.015","article-title":"Effects of intensive blood pressure lowering on kidney tubule injury in CKD: a longitudinal subgroup analysis in SPRINT","volume":"73","author":"Malhotra","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib111","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib112","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.2012.401","article-title":"Intensive glucose control improves kidney outcomes in patients with type 2 diabetes","volume":"83","author":"Perkovic","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib113","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinternmed.2011.2230","article-title":"Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes","volume":"172","author":"Coca","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib114","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1681\/ASN.2016030278","article-title":"Canagliflozin slows progression of renal function decline independently of glycemic effects","volume":"28","author":"Heerspink","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib116","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib117","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2213-8587(19)30180-9","article-title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial","volume":"7","author":"Mosenzon","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib118","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib119","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ndt\/gfz290","article-title":"Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial","volume":"35","author":"Heerspink","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","article-title":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Wheeler","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib121","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ckj\/sfy090","article-title":"The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study","volume":"11","author":"Herrington","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/S0140-6736(21)00519-5_bib122","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S0140-6736(21)00519-5_bib123","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2018.18269","article-title":"Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial","volume":"321","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(21)00519-5_bib124","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.kint.2018.10.018","article-title":"Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"Floege","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib126","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib127","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"318","author":"Lv","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(21)00519-5_bib128","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.ekir.2019.08.007","article-title":"Implementing the kidney health initiative surrogate efficacy endpoint in patients with IgA nephropathy (the PROTECT Trial)","volume":"4","author":"Barratt","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/S0140-6736(21)00519-5_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02166","article-title":"Complement inhibitors in clinical trials for glomerular diseases","volume":"10","author":"Zipfel","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib131","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib132","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib133","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy","volume":"21","author":"Polanco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib134","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1681\/ASN.2016091022","article-title":"Safety of rituximab compared with steroids and cyclophosphamide for idiopathic membranous nephropathy","volume":"28","author":"van den Brand","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.ki.5002215","article-title":"Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial","volume":"71","author":"Praga","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib136","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","article-title":"Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib137","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib138","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2215\/CJN.10240819","article-title":"Management of membranous nephropathy after MENTOR","volume":"15","author":"Trivin-Avillach","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib139","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib140","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib141","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib142","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1681\/ASN.2016050562","article-title":"Global cardiovascular and renal outcomes of reduced GFR","volume":"28","author":"Thomas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib143","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib144","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib145","first-page":"H1749","article-title":"Effect of intracellular and extracellular acidosis on sodium current in ventricular myocytes","volume":"268","author":"Watson","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib146","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","article-title":"FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability","volume":"307","author":"Silswal","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S0140-6736(21)00519-5_bib147","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2010.194","article-title":"FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease","volume":"78","author":"Yilmaz","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib148","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.18632\/aging.103183","article-title":"Klotho alleviates indoxyl sulfate-induced heart failure and kidney damage by promoting M2 macrophage polarization","volume":"12","author":"Lv","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/S0140-6736(21)00519-5_bib149","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1681\/ASN.V12112511","article-title":"Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure","volume":"12","author":"Cozzolino","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(86)80132-9","article-title":"Progressive vascular calcification with necrosis of extremities in hemodialysis patients: a possible role of iron overload","volume":"7","author":"Rubinger","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib151","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024382","article-title":"Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study","volume":"9","author":"Lioufas","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/S0140-6736(21)00519-5_bib152","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib153","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib154","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(16)30508-6","article-title":"The heart and vascular system in dialysis","volume":"388","author":"Wanner","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review","volume":"176","author":"Konstantinidis","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib156","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.jacc.2018.04.012","article-title":"Cardiovascular outcomes reported in hemodialysis trials","volume":"71","author":"O'Lone","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib157","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014908","article-title":"Sodium-glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"9","author":"Arnott","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S0140-6736(21)00519-5_bib158","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1681\/ASN.2013040392","article-title":"Physical activity and change in estimated GFR among persons with CKD","volume":"25","author":"Robinson-Cohen","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/2040622318785575","article-title":"The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review","volume":"9","author":"MacKinnon","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib160","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11255-018-1790-4","article-title":"The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review","volume":"50","author":"Afsar","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib161","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12882-019-1586-5","article-title":"Exercise therapy improves eGFR, and reduces blood pressure and BMI in non-dialysis CKD patients: evidence from a meta-analysis","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Nephrol"},{"issue":"suppl 2","key":"10.1016\/S0140-6736(21)00519-5_bib162","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1093\/ndt\/gfaa012","article-title":"Physical activity in chronic kidney disease and the EXerCise Introduction To Enhance trial","volume":"35","author":"Mallamaci","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib163","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ndt\/gfw452","article-title":"Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies","volume":"32","author":"Xia","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib164","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.ajkd.2016.02.052","article-title":"Smoking and adverse outcomes in patients with CKD: the Study of Heart and Renal Protection (SHARP)","volume":"68","author":"Staplin","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib165","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2215\/CJN.01120216","article-title":"A randomized crossover trial of dietary sodium restriction in stage 3\u20134 CKD","volume":"12","author":"Saran","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib166","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.jrn.2018.10.009","article-title":"Dietary sodium reduction reduces albuminuria: a cluster randomized trial","volume":"29","author":"Jardine","year":"2019","journal-title":"J Ren Nutr"},{"key":"10.1016\/S0140-6736(21)00519-5_bib167","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1681\/ASN.2013030285","article-title":"A randomized trial of dietary sodium restriction in CKD","volume":"24","author":"McMahon","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib168","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1573402111666150530204136","article-title":"Mechanisms of salt-sensitive hypertension","volume":"11","author":"Luzardo","year":"2015","journal-title":"Curr Hypertens Rev"},{"key":"10.1016\/S0140-6736(21)00519-5_bib169","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib170","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2215\/CJN.02250409","article-title":"Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib171","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/nep.13118","article-title":"Weight management strategies for those with chronic kidney disease: a consensus report from the Asia Pacific Society of Nephrology and Australia and New Zealand Society of Nephrology 2016 renal dietitians meeting","volume":"23","author":"Lambert","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/S0140-6736(21)00519-5_bib172","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","author":"Herrington","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib173","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(21)00519-5_bib174","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S0140-6736(21)00519-5_bib175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-156-6-201203200-00007","article-title":"Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"156","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib176","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M19-0087","article-title":"Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis","volume":"171","author":"Ha","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib177","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2020.3308","article-title":"Effect of apabetalone added to standard therapy on major adverse cardiovascular events in patients with recent acute coronary syndrome and type 2 diabetes: a randomized clinical trial","volume":"323","author":"Ray","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(21)00519-5_bib178","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2215\/CJN.16751020","article-title":"Effect of apabetalone on major adverse cardiovascular events in patients with chronic kidney disease, type-2 diabetes mellitus and recent acute coronary syndrome: results from the BETonMACE randomized controlled trial","volume":"16","author":"Kalantar-Zadeh","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib179","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1681\/ASN.2018080814","article-title":"Improving CKD-specific patient-reported measures of health-related quality of life","volume":"30","author":"Ware","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib180","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ekir.2017.12.007","article-title":"Abrupt decline in kidney function precipitating initiation of chronic renal replacement therapy","volume":"3","author":"Kovesdy","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/S0140-6736(21)00519-5_bib181","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(21)00519-5_bib182","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1681\/ASN.2011121185","article-title":"Does AKI truly lead to CKD?","volume":"23","author":"Rifkin","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib183","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(21)00519-5_bib184","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/ndt\/gfy178","article-title":"Acute kidney injury following coronary revascularization procedures in patients with advanced CKD","volume":"34","author":"Gaipov","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib185","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.ajkd.2015.07.022","article-title":"Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data","volume":"67","author":"Grams","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001307","article-title":"A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments","volume":"9","author":"Wyld","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib187","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/ndt\/gfm153","article-title":"Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5","volume":"22","author":"Murtagh","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib188","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2215\/CJN.13781119","article-title":"Dialysis regret: prevalence and correlates","volume":"15","author":"Saeed","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib189","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2215\/CJN.04840516","article-title":"Supportive care: comprehensive conservative care in end-stage kidney disease","volume":"11","author":"Murtagh","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib190","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jpainsymman.2020.04.030","article-title":"Impact of renal supportive care on symptom burden in dialysis patients: a prospective observational cohort study","volume":"60","author":"Siriwardana","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/S0140-6736(21)00519-5_bib191","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/nep.12064","article-title":"Renal supportive and palliative care: position statement","volume":"18","author":"Crail","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/S0140-6736(21)00519-5_bib192","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0272-6386(12)81017-1","article-title":"Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity","volume":"16","author":"Cheigh","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib193","first-page":"159","article-title":"Hepatitis C virus infection and global kidney health: the consensus proceedings of the International Federation of Kidney Foundations","volume":"23","author":"Saadi","year":"2020","journal-title":"Afr J Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib194","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1681\/ASN.2016010030","article-title":"Hepatitis C virus infection in chronic kidney disease","volume":"27","author":"Ladino","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib195","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.27664","article-title":"Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans","volume":"61","author":"Molnar","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/S0140-6736(21)00519-5_bib196","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study","volume":"386","author":"Roth","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib197","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ckj\/sfz188","article-title":"Kidney disease and mortality in patients with respiratory tract infections: a systematic review and meta-analysis","volume":"14","author":"Su","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/S0140-6736(21)00519-5_bib198","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000332","article-title":"Do influenza and pneumococcal vaccines prevent community-acquired respiratory infections among older people with diabetes and does this vary by chronic kidney disease? A cohort study using electronic health records","volume":"5","author":"McDonald","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S0140-6736(21)00519-5_bib199","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1681\/ASN.2020040534","article-title":"Epidemiology of COVID-19 in an urban dialysis center","volume":"31","author":"Corbett","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.jrn.2020.09.003","article-title":"Renal telenutrition for kidney health: leveraging telehealth and telemedicine for nutritional assessment and dietary management of patients with kidney disorders","volume":"30","author":"Kalantar-Zadeh","year":"2020","journal-title":"J Ren Nutr"},{"key":"10.1016\/S0140-6736(21)00519-5_bib201","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMcpc2002418","article-title":"Case 17-2020: a 68-year-old man with Covid-19 and acute kidney injury","volume":"382","author":"Sise","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib202","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1681\/ASN.2020040419","article-title":"Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology","volume":"31","author":"Batlle","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib203","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071704","article-title":"The yin and yang of ACE\/ACE2 pathways: the rationale for the use of renin-angiotensin system inhibitors in COVID-19 patients","volume":"9","author":"Zamai","year":"2020","journal-title":"Cells"},{"key":"10.1016\/S0140-6736(21)00519-5_bib204","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/ndt\/gfv466","article-title":"Chronic kidney disease in low- and middle-income countries","volume":"31","author":"Stanifer","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(21)00519-5_bib205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.mayocp.2019.09.028","article-title":"Association between income disparities and risk of chronic kidney disease: a nationwide cohort study of seven million adults in Korea","volume":"95","author":"Chang","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S0140-6736(21)00519-5_bib206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41581-020-00342-x","article-title":"Sustainable social development: tackling poverty to achieve kidney health equity","volume":"17","author":"Moosa","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib207","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S0140-6736(21)00519-5_bib208","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(21)00519-5_bib209","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8603-8-9","article-title":"The economic impact of non-communicable diseases on households in India","volume":"8","author":"Engelgau","year":"2012","journal-title":"Global Health"},{"key":"10.1016\/S0140-6736(21)00519-5_bib210","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/CIRCULATIONAHA.114.015124","article-title":"Association of race with mortality and cardiovascular events in a large cohort of US veterans","volume":"132","author":"Kovesdy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(21)00519-5_bib211","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.ajkd.2013.01.019","article-title":"Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system","volume":"62","author":"Derose","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(21)00519-5_bib212","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/sdi.12589","article-title":"Hemodialysis disparities in African Americans: the deeply integrated concept of race in the social fabric of our society","volume":"30","author":"Norris","year":"2017","journal-title":"Semin Dial"},{"key":"10.1016\/S0140-6736(21)00519-5_bib213","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11606-020-06280-5","article-title":"Examining the potential impact of race multiplier utilization in estimated glomerular filtration rate calculation on African-American care outcomes","volume":"36","author":"Ahmed","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S0140-6736(21)00519-5_bib214","first-page":"135","article-title":"Removal of race from estimates of kidney function: first, do no harm","volume":"325","author":"Norris","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(21)00519-5_bib215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5527\/wjn.v6.i4.168","article-title":"Fluid overload as a major target in management of cardiorenal syndrome: Implications for the practice of peritoneal dialysis","volume":"6","author":"Kazory","year":"2017","journal-title":"World J Nephrol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib216","doi-asserted-by":"crossref","first-page":"159.e1","DOI":"10.1016\/j.jpurol.2017.11.024","article-title":"Establishment of colonic dialysis model in uremic rats by right nephrectomy and left partial nephrectomy","volume":"14","author":"Kajbafzadeh","year":"2018","journal-title":"J Pediatr Urol"},{"key":"10.1016\/S0140-6736(21)00519-5_bib217","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/qjmed\/hcy260","article-title":"Simplified colonic dialysis with hemodialysis solutions delays the progression of chronic kidney disease","volume":"112","author":"Dai","year":"2019","journal-title":"QJM"},{"key":"10.1016\/S0140-6736(21)00519-5_bib218","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MNH.0000000000000569","article-title":"Perspiration interventions for conservative management of kidney disease and uremia","volume":"29","author":"Keller","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/S0140-6736(21)00519-5_bib219","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.jrn.2017.04.008","article-title":"Is there a role for diaphoresis therapy for advanced chronic kidney disease patients?","volume":"27","author":"Hanafusa","year":"2017","journal-title":"J Ren Nutr"},{"key":"10.1016\/S0140-6736(21)00519-5_bib220","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12825","article-title":"Urea transporters and sweat response to uremia","volume":"4","author":"Keller","year":"2016","journal-title":"Physiol Rep"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673621005195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673621005195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:26:05Z","timestamp":1758846365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673621005195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":220,"journal-issue":{"issue":"10302","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0140673621005195"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(21)00519-5","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(21)00519-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}